Avoidable waste related to inadequate methods and incomplete reporting of interventions: a systematic review of randomized trials performed in Sub-Saharan Africa

被引:9
作者
Diakou, Lee Aymar Ndounga [1 ,2 ,3 ]
Ntoumi, Francine [1 ]
Ravaud, Philippe [2 ,4 ,5 ]
Boutron, Isabelle [2 ,4 ]
机构
[1] FCRM, Brazzaville, Rep Congo
[2] INSERM, UMR 1153, Epidemiol & Biostat Sorbonne Paris Cite Ctr, METHODS, Paris, France
[3] Marien Ngouabi Univ, Brazzaville, Rep Congo
[4] Univ Tubingen, Inst Trop Med, Tubingen, Germany
[5] Hop Hotel Dieu, AP HP, Paris, France
关键词
Sub-Saharan Africa; Randomized controlled trials; Risk of bias; Reporting; Research implementation; NONPHARMACOLOGICAL INTERVENTIONS; JOURNAL INSTRUCTIONS; CONSORT STATEMENT; REDUCING WASTE; QUALITY; IMPACT; EXPLANATION;
D O I
10.1186/s13063-017-2034-0
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Randomized controlled trials (RCTs) are needed to improve health care in Sub-Saharan Africa (SSA). However, inadequate methods and incomplete reporting of interventions can prevent the transposition of research in practice which leads waste of research. The aim of this systematic review was to assess the avoidable waste in research related to inadequate methods and incomplete reporting of interventions in RCTs performed in SSA. Methods: We performed a methodological systematic review of RCTs performed in SSA and published between 1 January 2014 and 31 March 2015. We searched PubMed, the Cochrane library and the African Index Medicus to identify reports. We assessed the risk of bias using the Cochrane Risk of Bias tool, and for each risk of bias item, determined whether easy adjustments with no or minor cost could change the domain to low risk of bias. The reporting of interventions was assessed by using standardized checklists based on the Consolidated Standards for Reporting Trials, and core items of the Template for Intervention Description and Replication. Corresponding authors of reports with incomplete reporting of interventions were contacted to obtain additional information. Data were descriptively analyzed. Results: Among 121 RCTs selected, 74 (61%) evaluated pharmacological treatments (PTs), including drugs and nutritional supplements; and 47 (39%) nonpharmacological treatments (NPTs) (40 participative interventions, 1 surgical procedure, 3 medical devices and 3 therapeutic strategies). Overall, the randomization sequence was adequately generated in 76 reports (62%) and the intervention allocation concealed in 48 (39%). The primary outcome was described as blinded in 46 reports (38%), and incomplete outcome data were adequately addressed in 78 (64%). Applying easy methodological adjustments with no or minor additional cost to trials with at least one domain at high risk of bias could have reduced the number of domains at high risk for 24 RCTs (19%). Interventions were completely reported for 73/121 (60%) RCTs: 51/74 (68%) of PTs and 22/47 (46%) of NPTs. Additional information was obtained from corresponding authors for 11/48 reports (22%). Conclusion: Inadequate methods and incomplete reporting of published SSA RCTs could be improved by easy and inexpensive methodological adjustments and adherence to reporting guidelines.
引用
收藏
页数:11
相关论文
共 40 条
[31]   Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review [J].
Plint, Amy C. ;
Moher, David ;
Morrison, Andra ;
Schulz, Kenneth ;
Altman, Douglas G. ;
Hill, Catherine ;
Gaboury, Isabelle .
MEDICAL JOURNAL OF AUSTRALIA, 2006, 185 (05) :263-267
[32]   Treating Individuals 1 - External validity of randomised controlled trials: "To whom do the results of this trial apply?"' [J].
Rothwell, PM .
LANCET, 2005, 365 (9453) :82-93
[33]   Quality of descriptions of treatments: a review of published randomised controlled trials [J].
Schroter, Sara ;
Glasziou, Paul ;
Heneghan, Carl .
BMJ OPEN, 2012, 2 (06)
[34]  
Schulz K.F., 2010, J PHARMACOL PHARMACO, V340, pc332, DOI DOI 10.4103/0976-500X.72352
[35]   Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa [J].
Seyler, Catherine ;
Adje-Toure, Christiane ;
Messou, Eugene ;
Dakoury-Dogbo, Nicole ;
Rouet, Francois ;
Gabillard, Delphine ;
Nolan, Monica ;
Toure, Siaka ;
Anglaret, Xavier .
AIDS, 2007, 21 (09) :1157-1164
[36]   African HIV/AIDS Trials Are More Likely to Report Adequate Allocation Concealment and Random Generation than North American Trials [J].
Siegfried, Nandi ;
Clarke, Michael ;
Volmink, Jimmy ;
Van der Merwe, Lize .
PLOS ONE, 2008, 3 (10)
[37]   Are Reports of Randomized Controlled Trials Improving over Time? A Systematic Review of 284 Articles Published in High-Impact General and Specialized Medical Journals [J].
To, Matthew J. ;
Jones, Jennifer ;
Emara, Mohamed ;
Jadad, Alejandro R. .
PLOS ONE, 2013, 8 (12)
[38]   Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals [J].
Turner, Lucy ;
Shamseer, Larissa ;
Altman, Douglas G. ;
Weeks, Laura ;
Peters, Jodi ;
Kober, Thilo ;
Dias, Sofia ;
Schulz, Kenneth F. ;
Plint, Amy C. ;
Moher, David .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (11)
[39]  
Yordanov Y, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/BMJ.h809, 10.1136/bmj.h809]
[40]   Randomized Controlled Trials of HIV/AIDS Prevention and Treatment in Africa: Results from the Cochrane HIV/AIDS Specialized Register [J].
Zani, Babalwa ;
Pienaar, Elizabeth D. ;
Oliver, Joy ;
Siegfried, Nandi .
PLOS ONE, 2011, 6 (12)